Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxil in children and adolescents with MDD
NCT00812812Phase 4Terminated
- Sponsor
- GSK
- Start
- Mar 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine in major depressive disorder (MDD), sponsored by GSK. Started Mar 2009; status: terminated.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00812812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812812.